Oxford Instruments (OXIG) AI Stock Analysis

• Market Cap: $1.08B
• Dividend Yield: 1.17%
• Average Volume (3M): 99.65K
• Price to Earnings (P/E): 42.2
• Beta (1Y): 1.49
• Revenue Growth: 6.42%
• EPS Growth: -48.89%
• Country: UK
• Employees: 2,000
• Sector: Technology
• Sector Strength: 88
• Industry: Semiconductors
• EPS (TTM): 0.67
• Shares Outstanding: 57,079,082
• 10 Day Avg. Volume: 143,493
• 30 Day Avg. Volume: 99,648
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): N/A
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: 0.88
• Enterprise Value/Revenue: 1.91
• Enterprise Value/Gross Profit: 3.78
• Enterprise Value/Ebitda: 16.99
• 1Y Price Target: $2,309.46
• Price Target Upside: 21.42% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 4

• Rating: 69 Neutral
• Price Target: 2,017.00p ▲(6.05% Upside)

Oxford Instruments' strong financial performance is the primary driver of its score, supported by consistent revenue growth and solid profitability margins. However, high valuation and neutral technical indicators suggest caution. Addressing liquidity and profitability challenges will be crucial for future growth.

Positive Factors

Negative Factors

Oxford Instruments Business Overview & Revenue Model

Company Description

Oxford Instruments plc, through its subsidiaries, researches, develops, manufactures, rents, sells, and services tools and systems in the United Kingdom, China, Japan, the United States, Germany, rest of Europe, rest of Asia, and internationally. It operates through e Materials & Characterisation, Research & Discovery, and Service & Healthcare. The company offers atomic force microscopy products; tools for use in research and development across a range of applications, including semiconductors, renewable energy, mining, metallurgy, and forensics; etch and deposition processing equipment and solutions for use in power and RF devices, VCSELs/lasers, 2D materials, augmented reality, biomems, failure analysis, HBLEDs, infrared sensors, MEMS and sensors, and quantum; and low temperature systems comprising wet systems, magnet systems, instrumentation products, and custom and specialty systems. It also provides optical imaging products; and nuclear magnetic resonance (NMR) instruments, including NMR spectrometers, QC/QA analyzers, and rock core analyzers for use in applications, such as agriculture and food, automotive and aviation, building and construction, chemicals, environment, illicit drugs testing, mining and minerals, pharma, polymers, rock core analysis, textiles, and education. In addition, the company offers MRI and CT serving products; scientific cameras spectroscopy solutions, microscopy systems, and software for applications comprising astronomy, bio imaging and life science, energy generation and storage, forensics and environment, photonics, quantum technology, semiconductors, microelectronics, and data storage; and manufacture of x-ray tubes, power supplies, and integrated x-ray sources for analytical, medical imaging, food quality and packaging inspection, and industrial NDT markets. Oxford Instruments plc was founded in 1959 and is headquartered in Abingdon, the United Kingdom.

How the Company Makes Money

Oxford Instruments generates revenue primarily through the sale of its high-tech equipment and services across its three main sectors. The key revenue streams include the sale of products such as cryogenic systems and analytical instruments, which are often complemented by ongoing service contracts and maintenance agreements. Additionally, the company benefits from the sale of spare parts and consumables. Significant partnerships with research institutions, universities, and industrial clients also contribute to its earnings, as these collaborations often lead to long-term contracts and joint ventures that secure a stable income. Furthermore, the company invests in research and development to innovate and expand its product offerings, which can lead to increased market share and revenue growth.

Oxford Instruments Financial Statement Overview

Summary

Oxford Instruments shows strong revenue growth and profitability margins, with a solid equity position. However, challenges in net income and liquidity pressures need attention.

Income Statement

Oxford Instruments has demonstrated solid revenue growth over the years, with a revenue increase from £317.4 million in 2020 to £500.6 million in 2025. The gross profit margin remains healthy, consistently around 50% or higher, indicating efficient production and cost management. However, the decline in net income from 2024 to 2025 suggests some challenges in managing operating costs or other expenses, impacting profitability.

Balance Sheet

The company's balance sheet shows a strong equity position, with a steadily increasing stockholders' equity from £251.6 million in 2020 to £376.1 million in 2025. The debt-to-equity ratio remains low, reflecting prudent financial leverage, which mitigates risk. However, the declining cash and equivalents from 2021 to 2023 could indicate pressures on liquidity, which improved slightly in 2025.

Cash Flow

Cash flow from operations has been generally positive, supporting the company's operations and investments. The increase in free cash flow in 2025 compared to 2024 indicates improved cash efficiency. However, fluctuations in investing cash flow, particularly high capital expenditures in some years, suggest potential variability in investment strategies.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	500.60M	500.60M	470.40M	444.70M	367.30M	318.50M
Gross Profit	253.20M	258.80M	242.40M	219.50M	176.40M	153.90M
EBITDA	56.30M	63.10M	93.10M	94.80M	67.40M	71.60M
Net Income	26.00M	26.00M	50.70M	58.60M	38.60M	41.80M
Balance Sheet
Total Assets	604.80M	604.80M	606.30M	572.00M	514.00M	450.70M
Cash, Cash Equivalents and Short-Term Investments	94.10M	94.10M	97.80M	112.70M	96.40M	128.00M
Total Debt	40.90M	40.90M	47.40M	43.90M	28.90M	37.90M
Total Liabilities	228.70M	228.70M	240.60M	228.00M	197.60M	184.50M
Stockholders Equity	376.10M	376.10M	365.70M	344.00M	316.40M	266.20M
Cash Flow
Free Cash Flow	35.10M	33.20M	14.70M	34.70M	34.50M	36.70M
Operating Cash Flow	49.50M	49.10M	42.40M	67.60M	49.20M	41.80M
Investing Cash Flow	-27.80M	-27.40M	-37.50M	-37.50M	-45.70M	-4.90M
Financing Cash Flow	-18.40M	-18.40M	-18.00M	-16.60M	-15.70M	-30.50M

Oxford Instruments Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 1902.00
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:OXIG, the sentiment is Positive. The current price of 1902 is above the 20-day moving average (MA) of 1826.40, above the 50-day MA of 1854.74, and above the 200-day MA of 1880.26, indicating a bullish trend. The MACD of 6.58 indicates Negative momentum. The RSI at 60.86 is Neutral, neither overbought nor oversold. The STOCH value of 63.47 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for GB:OXIG.

Oxford Instruments Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
RSW	74 Outperform	2.63B	31.35	0.00%	1.55%	3.15%	-13.57%
KNOS	71 Outperform	1.04B	30.47	25.77%	3.28%	-3.96%	-26.93%
OXIG	69 Neutral	$1.08B	42.25	7.03%	1.17%	6.42%	-48.89%
SXS	63 Neutral	4.06B	69.96	16.89%	1.86%	0.07%	-78.33%
IQE	47 Neutral	75.60M	-1.95	-28.47%	―	2.41%	-16.47%
Sector *	61 Neutral	$37.18B	12.37	-10.20%	1.83%	8.50%	-7.62%

Oxford Instruments Corporate Events

Oxford Instruments Completes Share Buyback

Oxford Instruments has executed a share buyback program, purchasing 24,028 of its own ordinary shares at an average price of 1783.9481 pence per share. This move reduces the total number of shares in issue to 57,232,157, impacting the company’s voting rights and potentially influencing shareholder interests.

The most recent analyst rating on (GB:OXIG) stock is a Hold with a £1961.00 price target. To see the full list of analyst forecasts on Oxford Instruments stock, see the GB:OXIG Stock Forecast page.

Oxford Instruments Announces Updated Voting Rights and Share Capital

Oxford Instruments plc announced that as of 29 August 2025, its issued share capital with voting rights consists of 57,309,182 ordinary shares. This figure is important for shareholders to determine their notification requirements under the FCA’s Disclosure Guidance and Transparency Rules, impacting how they manage their shareholdings.

The most recent analyst rating on (GB:OXIG) stock is a Hold with a £1991.00 price target. To see the full list of analyst forecasts on Oxford Instruments stock, see the GB:OXIG Stock Forecast page.

Oxford Instruments CEO Acquires Shares Under Incentive Plan

Oxford Instruments plc announced a transaction involving its Chief Executive Officer, Richard Tyson, who acquired Partnership Shares and Matching Shares under the company’s Share Incentive Plan. This transaction, conducted on the London Stock Exchange, reflects the company’s adherence to the EU Market Abuse Regulation, indicating a commitment to transparency and regulatory compliance.

The most recent analyst rating on (GB:OXIG) stock is a Buy with a £2500.00 price target. To see the full list of analyst forecasts on Oxford Instruments stock, see the GB:OXIG Stock Forecast page.

Oxford Instruments Executes Share Buyback Program

Oxford Instruments has executed a share buyback program, purchasing 16,755 of its own ordinary shares at an average price of 1834.6167 pence per share. This transaction, conducted through Numis Securities Limited, will result in a total of 57,508,549 ordinary shares in issue, impacting the company’s share capital and potentially influencing shareholder value.

The most recent analyst rating on (GB:OXIG) stock is a Buy with a £2500.00 price target. To see the full list of analyst forecasts on Oxford Instruments stock, see the GB:OXIG Stock Forecast page.

Oxford Instruments Executes Share Buyback

Oxford Instruments, a company involved in scientific and industrial instrumentation, announced the purchase of 30,000 of its own shares as part of a share buyback program. The shares were acquired at an average price of 1791.5901 pence each, with the total number of shares in issue now standing at 57,610,479. This move is part of the company’s strategy to manage its capital structure and potentially enhance shareholder value.

The most recent analyst rating on (GB:OXIG) stock is a Buy with a £2500.00 price target. To see the full list of analyst forecasts on Oxford Instruments stock, see the GB:OXIG Stock Forecast page.

Oxford Instruments Announces Total Voting Rights and Share Capital Update

Oxford Instruments plc has announced its total voting rights and share capital as of July 31, 2025, which consists of 57,710,041 ordinary shares with voting rights. This information is crucial for shareholders to determine their reporting obligations under the FCA’s Disclosure Guidance and Transparency Rules, impacting how they manage their interests in the company.

The most recent analyst rating on (GB:OXIG) stock is a Hold with a £2230.00 price target. To see the full list of analyst forecasts on Oxford Instruments stock, see the GB:OXIG Stock Forecast page.

Oxford Instruments CEO to Step Down from Videndum Board

Oxford Instruments plc announced that Richard Tyson, their Chief Executive Officer, will step down from his role as a non-executive director at Videndum plc on 31 July 2025. This move may influence the company’s strategic focus and leadership dynamics, potentially impacting its market positioning and stakeholder interests.

The most recent analyst rating on (GB:OXIG) stock is a Buy with a £2500.00 price target. To see the full list of analyst forecasts on Oxford Instruments stock, see the GB:OXIG Stock Forecast page.

Oxford Instruments AGM 2025: All Resolutions Passed

Oxford Instruments plc successfully held its Annual General Meeting on July 28, 2025, where all proposed resolutions were passed by shareholders. The resolutions included the adoption of the 2025 Annual Report, approval of the Directors’ Remuneration Report, declaration of a final dividend, and the election and re-election of several directors. The approval of these resolutions reflects strong shareholder support and positions the company to continue its strategic initiatives and maintain robust governance practices.

The most recent analyst rating on (GB:OXIG) stock is a Buy with a £2500.00 price target. To see the full list of analyst forecasts on Oxford Instruments stock, see the GB:OXIG Stock Forecast page.